111 related articles for article (PubMed ID: 34848972)
1. Erratum: Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation [Corrigendum].
Onco Targets Ther; 2021; 14():5295-5296. PubMed ID: 34848972
[TBL] [Abstract][Full Text] [Related]
2. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation.
Sun J; Shen D; Gao Y; Zheng Y; Zhao L; Maa M; Liu H; Chen X
Onco Targets Ther; 2020; 13():7973-7984. PubMed ID: 32848421
[TBL] [Abstract][Full Text] [Related]
3. Erratum:
Onco Targets Ther; 2020; 13():10761. PubMed ID: 33116649
[TBL] [Abstract][Full Text] [Related]
4. Erratum: MIIP is Downregulated in Gastric Cancer and Its Forced Expression Inhibits Proliferation and Invasion of Gastric Cancer Cells in vitro and in vivo [Corrigendum].
Onco Targets Ther; 2021; 14():2989-2990. PubMed ID: 33986600
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells [Corrigendum].
Onco Targets Ther; 2021; 14():697-698. PubMed ID: 33531817
[TBL] [Abstract][Full Text] [Related]
6. Erratum: miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum].
Onco Targets Ther; 2020; 13():5589. PubMed ID: 32606773
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer [Corrigendum].
Onco Targets Ther; 2020; 13():8181. PubMed ID: 32904014
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum].
Onco Targets Ther; 2022; 15():1143-1145. PubMed ID: 36238137
[TBL] [Abstract][Full Text] [Related]
9. Erratum: RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum].
Onco Targets Ther; 2022; 15():529-530. PubMed ID: 35591879
[TBL] [Abstract][Full Text] [Related]
10. Erratum: ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer [Corrigendum].
Onco Targets Ther; 2021; 14():4641-4643. PubMed ID: 34511933
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Gastric H
Onco Targets Ther; 2022; 15():527-528. PubMed ID: 35591880
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Traditional Chinese Medicine
Onco Targets Ther; 2022; 15():77-79. PubMed ID: 35087275
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Effects of Vitamin K3 Combined with UVB on the Proliferation and Apoptosis of Cutaneous Squamous Cell Carcinoma A431 Cells [Corrigendum].
Onco Targets Ther; 2020; 13():4917. PubMed ID: 32581552
[TBL] [Abstract][Full Text] [Related]
14. Erratum: LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p [Corrigendum].
Onco Targets Ther; 2019; 12():mmmmmmmdccxxxvii-mmmmmmmdccxxxviii. PubMed ID: 31571931
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum].
Onco Targets Ther; 2021; 14():5333-5334. PubMed ID: 34858032
[TBL] [Abstract][Full Text] [Related]
16. Erratum: PWP1 Promotes the Malignant Phenotypes of Lung Cancer Cells by Interacting with DVL2 and Merlin [Corrigendum].
Onco Targets Ther; 2020; 13():10763-10764. PubMed ID: 33122914
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells [Corrigendum].
Onco Targets Ther; 2020; 13():4507-4508. PubMed ID: 32547081
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Effects of Adenosine on Apoptosis of Ovarian Cancer A2780 Cells via ROS and Caspase Pathways [Corrigendum].
Onco Targets Ther; 2020; 13():1871-1872. PubMed ID: 32184621
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Upregulated LINC00565 Accelerates Ovarian Cancer Progression by Targeting GAS6 [Corrigendum].
Onco Targets Ther; 2020; 13():865-866. PubMed ID: 32099390
[TBL] [Abstract][Full Text] [Related]
20. Erratum: IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum].
Onco Targets Ther; 2020; 13():12253-12254. PubMed ID: 33273830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
